Bingyu Li received his Master's Degree in Clinical Medicine from Tongji University in 2019. He worked as a Clinical Research Physician at the Luoxin Pharmaceutical Institute (2022–2024). In 2025, he moved to the Mount Sinar West/ Morningside in New York City and is training as a pathology resident. His research topics mainly include cancer therapy, target therapy, clinical trials, cardiology, myocardial infarction, and arrhythmia.
Bingyu Li received his Master's Degree in Clinical Medicine from Tongji University in 2019. He worked as a Clinical Research Physician at the Luoxin Pharmaceutical Institute (2022–2024). In 2025, he moved to the Mount Sinar West/ Morningside in New York City and is training as a pathology resident. His research topics mainly include cancer therapy, target therapy, clinical trials, cardiology, myocardial infarction, and arrhythmia.